What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Magnetic resonance imaging
Michael W. Weiner spends much of his time researching Alzheimer's disease, Neuroimaging, Internal medicine, Alzheimer's Disease Neuroimaging Initiative and Neuroscience.
His studies in Alzheimer's disease integrate themes in fields like Biomarker and Dementia, Cognitive decline.
His Neuroimaging research also works with subjects such as
- Cognition which is related to area like Audiology,
- Clinical trial which intersects with area such as MEDLINE.
His studies deal with areas such as Endocrinology, Oncology and Cardiology as well as Internal medicine.
His Alzheimer's Disease Neuroimaging Initiative study which covers Cognitive disorder that intersects with Neuropsychology.
The various areas that he examines in his Neuroscience study include Alzheimer's disease biomarkers and Neurodegeneration.
His most cited work include:
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2965 citations)
- The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. (2619 citations)
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. (2323 citations)
What are the main themes of his work throughout his whole career to date?
Michael W. Weiner mainly focuses on Internal medicine, Alzheimer's disease, Neuroscience, Pathology and Disease.
He has researched Internal medicine in several fields, including Endocrinology, Oncology and Cardiology.
He is involved in the study of Alzheimer's disease that focuses on Alzheimer's Disease Neuroimaging Initiative in particular.
Many of his studies on Neuroscience apply to Audiology as well.
Michael W. Weiner combines subjects such as White matter and Temporal lobe with his study of Pathology.
His work carried out in the field of Neuroimaging brings together such families of science as Clinical trial, Magnetic resonance imaging, Artificial intelligence, Biomarker and Brain mapping.
He most often published in these fields:
- Internal medicine (30.03%)
- Alzheimer's disease (27.65%)
- Neuroscience (25.48%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (30.03%)
- Disease (24.00%)
- Neuroimaging (23.89%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Disease, Neuroimaging, Cognition and Cognitive decline.
In his study, Apolipoprotein E is strongly linked to Oncology, which falls under the umbrella field of Internal medicine.
His Disease research incorporates themes from Clinical psychology and Artificial intelligence.
In Neuroimaging, Michael W. Weiner works on issues like White matter, which are connected to Hyperintensity.
His Cognitive decline research is multidisciplinary, incorporating perspectives in Gerontology and Clinical significance.
His Alzheimer's disease study is concerned with Pathology in general.
Between 2016 and 2021, his most popular works were:
- Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. (280 citations)
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons. (183 citations)
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons. (183 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Magnetic resonance imaging
The scientist’s investigation covers issues in Internal medicine, Alzheimer's disease, Cognitive decline, Disease and Dementia.
His Internal medicine study incorporates themes from Positron emission tomography, Precuneus and Cardiology.
Alzheimer's disease is a subfield of Pathology that he studies.
The Cognitive decline study combines topics in areas such as Construct validity, Physical therapy, Oncology and Cohort.
Michael W. Weiner has included themes like Cognition, Neuroimaging, Neuroscience and Clinical trial in his Disease study.
His studies deal with areas such as Apolipoprotein E, Affect and Clinical psychology as well as Dementia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
